Ginkgo said on Tuesday it was planning to go public through a merger with a blank-check vehicle backed by former Hollywood executives Harry Sloan and Jeff Sagansky, in one of the biggest such deals that values the biotech company at $17.5 billion.
UPDATE 3-Biotech firm Ginkgo to merge with Harry Sloan-led SPAC in $17.5 bln deal
2021-05-12T02:10:58-04:00May 12th, 2021|
Related Posts
-
7 Dividend Stocks to Buy on the Dip: May 2024
May 22nd, 2024